Have a website account? Login or Register for exclusive

Other Surgery

Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer


This video is available to purchase. $0.0 Purchase


Cite this video as: Lucille L. Ye . Professor Charles E. Geyer: neoadjuvant therapy is becoming standard of care for HER2+ breast cancer. Asvide 2016; 3: 412. doi:10.21037/asvide.2016.412

Your Comments

comments powered by Disqus

Published online:

Submitted at: August 20, 2016. Accepted for publication: August 25, 2016.
DOI: 10.21037/asvide.2016.412

Authors

Lucille L. Ye 1

Affiliations

1 Chinese Clinical Oncology

Corresponding Author

Lucille L. Ye, Email: editor@thecco.net